3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
23
Carcinoma, Non-Small-Cell Lung
12
Colorectal Neoplasms
8
Biliary Tract Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Mesothelioma, Malignant
5
Melanoma
5
Liver Neoplasms
5
Cholangiocarcinoma
5
Urinary Bladder Neoplasms
4
Prostatic Neoplasms
4
Neoplasms
4
Diabetes Mellitus, Insulin-Dependent, 12
4
Neoplasm Metastasis
3
Lung Neoplasms
3
Head and Neck Neoplasms
3
Fallopian Tube Neoplasms
3
Carcinoma, Renal Cell
3
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Recurrence
2
Ovarian Neoplasms
2
Neoplasms, Germ Cell and Embryonal
2
Mesothelioma
2
Gallbladder Neoplasms
2
Endometrial Neoplasms
2
Adenocarcinoma Of Esophagus
2
Vascular Neoplasms
1
Uveal Melanoma
1
Interventions
Gemcitabine
2
tremelimumab
1
irinotecan sucrosofate
1
durvalumab
1
Taxes
1
Oxaliplatin
1
Medical Marijuana
1
Leucovorin
1
Fluorouracil
1
Chemoradiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Pancreatic Cancer Non-resectable
×
tremelimumab
×
Clear all
NCT04156087
2024-09-19
MIMIPAC
University Hospital, Gasthuisberg
Phase 2
Completed
12 enrolled